SHAH CAPITAL MANAGEMENT: NOVAVAX INC (NVAX): Quarterly 13F Position History
As of Q1 2026, SHAH CAPITAL MANAGEMENT reported 14,845,097 shares of NOVAVAX INC (NVAX), worth $120.8M and representing 23.2% of its 13F equity book. Quarter-over-quarter share count change: + 286,317 (+2.0%) . The position first appeared in Q4 2022 and has been disclosed across 14 13F-HR filings in Pactolio's tracked window.
- 14,845,097Shares Held (Latest Filing)
- $120.8MReported Market Value (Latest Filing)
- 23.2%Portfolio Weight (% of 13F Equity Book)
- +286,317Quarter-over-Quarter Share Change
- +$23.0MQuarter-over-Quarter Value Change
- 14,845,097Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 14 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 14,845,097 | +286,317 | +2.0% | $120.8M | 23.2% | $8.1 |
| Q4 2025 | 14,558,780 | +2,747,000 | +23.3% | $97.8M | 18.9% | $6.7 |
| Q3 2025 | 11,811,780 | +300,000 | +2.6% | $102.4M | 18.3% | $8.7 |
| Q2 2025 | 11,511,780 | +379,934 | +3.4% | $72.5M | 14.1% | $6.3 |
| Q1 2025 | 11,131,846 | 17,000 | -0.2% | $71.4M | 14.6% | $6.4 |
| Q4 2024 | 11,148,846 | +1,333,305 | +13.6% | $89.6M | 18.1% | $8.0 |
| Q3 2024 | 9,815,541 | +153,451 | +1.6% | $124.0M | 24.2% | $12.6 |
| Q2 2024 | 9,662,090 | +1,544,263 | +19.0% | $122.3M | 26.5% | $12.7 |
| Q1 2024 | 8,117,827 | +337,071 | +4.3% | $38.8M | 10.9% | $4.8 |
| Q4 2023 | 7,780,756 | +1,450,000 | +22.9% | $37.3M | 9.6% | $4.8 |
| Q3 2023 | 6,330,756 | +850,000 | +15.5% | $45.8M | 10.8% | $7.2 |
| Q2 2023 | 5,480,756 | +1,229,680 | +28.9% | $40.7M | 10.5% | $7.4 |
| Q1 2023 | 4,251,076 | +3,536,076 | +494.6% | $29.5M | 8.6% | $6.9 |
| Q4 2022 | 715,000 | — | — | $7.3M | 1.7% | $10.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did SHAH CAPITAL MANAGEMENT first disclose a NVAX position in 13F-HR filings?
SHAH CAPITAL MANAGEMENT first reported NOVAVAX INC (NVAX) on its 13F-HR filing for the period ending 2022-12-31 (Q4 2022). The position has appeared on 14 reported quarters within Pactolio's tracked window.
What was SHAH CAPITAL MANAGEMENT's most recent quarter-over-quarter share-count change in NVAX?
Between Q4 2025 and Q1 2026, SHAH CAPITAL MANAGEMENT added 286,317 shares of NVAX (+2.0%), bringing the total reported position to 14,845,097 shares at a market value of $120.8M.
Does the implied price-per-share represent SHAH CAPITAL MANAGEMENT's cost basis in NVAX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.